Key result
Conventional pacemakers for CSP cost significantly less than standard triple-chamber devices for CRT.
Why the study?
Triple-chamber pacemakers for CRT can be cost-prohibitive, whereas His-Purkinje system pacing can achieve resynchronization with relatively inexpensive conventional pacemakers, but comparative device costs were needed to guide clinical decision-making.
Does conduction system pacing (CSP)-based CRT using conventional pacemakers reduce device costs compared to biventricular pacing (BVP)-based CRT using triple-chamber pacemakers?
Does conduction system pacing (CSP)-based CRT using conventional pacemakers reduce device costs compared to biventricular pacing (BVP)-based CRT using triple-chamber pacemakers?
Conduction system pacing-based CRT using conventional pacemakers offers a significant cost advantage over biventricular pacing-based CRT using triple-chamber devices, providing a more affordable option for patients.
Answers are grounded in this paper and cite their sources.
May reduce CRT device costs with conventional pacemakers for CSP; leaves open whether outcomes match triple-chamber BVP.
BACKGROUND: Cardiac resynchronization therapy (CRT) is an established treatment option for heart failure patients. However, the implementation of triple-chamber pacemakers can be cost-prohibitive. His-Purkinje system pacing (HPSP) can also enable cardiac resynchronization, and it can be achieved with relatively inexpensive conventional pacemakers. HYPOTHESIS: This article aims to comparatively evaluate the cost of implanting devices in different CRT strategies to provide meaningful guidance for clinical decision-making by electrophysiologists. METHODS: Data was collected on the prices, designed life, and price/designed life of multiple mainstream models of CRT-P, CRT-D, dual-chamber pacemakers, and single-chamber pacemakers that were sold in the Chinese market in 2022. The prices, designed lives, and price/designed life of different pacemaker models were then compared. RESULTS: The costs of CRT-P and CRT-D (13008.44 ± 2752.30 USD and 22043.36 ± 3676.25 USD) were significantly higher than those of conventional pacemakers (dual-chamber: 11142.39 ± 4273.85 USD and single-chamber: 5634.28 ± 2032.80 USD) (p < .05). Additionally, the price/designed life of conventional pacemakers (dual-chamber: 839.63 ± 258.62 US dollar/year and single-chamber: 435.86 ± 125.44 US dollar/year) was significantly better than that of CRT-P and CRT-D (1386.91 ± 266.73 and 2585.53 ± 520.27 US dollar/year, respectively) (p < .05). CONCLUSION: Conduction system pacing (CSP)-based CRT is more cost-effective than BVP-based CRT. Furthermore, CSP-based CRT can achieve cardiac resynchronization with conventional pacemakers and may be a good option for HF patients who do not need defibrillation.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2023) studied Heart failure requiring cardiac resynchronization therapy (n=37). Conventional pacemakers (dual-chamber and single-chamber) vs. Triple-chamber pacemakers (CRT-P and CRT-D) was evaluated on Device price (USD) (p=<.05). Conventional pacemakers used for conduction system pacing were less expensive (dual-chamber: 11,142 USD; single-chamber: 5,634 USD) than triple-chamber pacemakers.
Synapse has enriched 10 related papers. Consider them for comparative context: